Johnson & Johnson recalls Topamax for odor

By Parija Kavilanz, senior writer


NEW YORK (CNNMoney.com) -- Johnson & Johnson on Thursday announced a recall of 57,000 bottles of the prescription anti-seizure medication Topamax following consumer complaints of an "uncharacteristic odor."

Johnson & Johnson (JNJ, Fortune 500) said the recall represents two lots of the Topamax 100 mg tablets made by its Ortho-McNeil Neurologics division.

The affected drugs were shipped and distributed between Oct. 19, 2010 and Dec. 28, 2010 in the United States and Puerto Rico.

The company said it believes fewer than 6,000 bottles of the medicine remain in the marketplace to be recalled.

However, Ortho-McNeil Neurologics said it does not anticipate a product shortage resulting from the recall.

J&J said it initiated the recall after receiving four consumer reports of an uncharacteristic odor thought to be caused by trace amounts of TBA (2,4,6 tribromoanisole).

Last month, the government announced it was taking over three Tylenol plants operated by McNeil following a wave of drug recalls and a Food and Drug Administration criminal investigation into safety issues at the factories.

McNeil recalled more than 50 million bottles of Tylenol, Motrin and Benadryl products in 2010 after receiving similar complaints of an unusual moldy, musty odor.

The company said at the time that the smell was caused by trace amounts of the same chemical, TBA, which is applied to wooden pallets used to transport and store packaging materials.

While not considered to be toxic, J&J said TBA can generate an offensive odor, and a very small number of patients have reported temporary gastrointestinal symptoms.

As it relates to Topamax, the company said there have been no reported serious adverse effects caused by the presence of TBA.

The company said no consumer actions are required. But patients taking Topamax 100 mg tablets who experience an uncharacteristic odor should return the tablets to their pharmacist, and contact their health care professional if they have questions.

J&J said patients or health care professionals can contact the Topamax helpline at 1-866-536-4398 Monday through Friday, 9 a.m. to 5 p.m. ET.

Additional information about the recall can be found on Topamax.com, RxForSafety.com and OrthoMcNeilNeurologics.com. To top of page

Index Last Change % Change
Dow 25,219.38 19.01 0.08%
Nasdaq 7,239.46 -16.97 -0.23%
S&P 500 2,732.22 1.02 0.04%
Treasuries 2.88 -0.01 -0.48%
Data as of 5:38am ET
Company Price Change % Change
General Electric Co 15.05 0.20 1.35%
Bank of America Corp... 31.97 -0.24 -0.75%
Micron Technology In... 44.21 0.71 1.63%
Advanced Micro Devic... 11.82 -0.37 -3.04%
Ford Motor Co 10.61 -0.15 -1.39%
Data as of Feb 16
Sponsors

Sections

Adam Rippon, one of the first openly gay U.S. athletes to compete at the Olympics, has turned down a job as a correspondent for NBC at the Winter Games in South Korea. More

Unfortunately, economic expansions don't last forever. Eventually, a recession comes along and ruins the party. More

Big companies like Samsung and Intel are showing off self-driving vehicles, virtual-reality viewing stations and super-fast video streaming. More

The 4% rule has long been the standard as far as retirement plan withdrawals go. But it certainly isn't perfect. More